P2RY13 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesGPCR1; GPR86; GPR94; P2Y13; SP174; FKSG77
ProductOrderP
Clone#6G12E10
Entrez GenelD53829
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human P2RY13 (AA: 1-49) expressed in E. Coli.
MW40.8kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
FCM (Flow Cytometry)1/200 - 1/400
WB (Western Blot)1/500 - 1/2000
Sequence
17899
Catalog#: 30760
Inquire
Contact us to order
Images
Elisa
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Western Blot
Figure 2:Western blot analysis using P2RY13 mAb against human P2RY13 (AA: 1–49) recombinant protein. (Expected MW is 31.6 kDa)
Figure 2:Western blot analysis using P2RY13 mAb against human P2RY13 (AA: 1–49) recombinant protein. (Expected MW is 31.6 kDa)
Western Blot
Figure 3:Western blot analysis using P2RY13 mAb against HEK293 (1) and P2RY13 (AA: 1–49)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3:Western blot analysis using P2RY13 mAb against HEK293 (1) and P2RY13 (AA: 1–49)-hIgGFc transfected HEK293 (2) cell lysate.
Flow cytometric
Figure 4:Flow cytometric analysis of Hela cells using P2RY13 mouse mAb (green) and negative control (red).
Figure 4:Flow cytometric analysis of Hela cells using P2RY13 mouse mAb (green) and negative control (red).
Product Overview
DescriptionThe product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is activated by ADP.
References (references)
References (references)J Cell Sci. 2012 Jan 1;125(Pt 1):176-88.
J Pharmacol Exp Ther. 2002 May;301(2):705-13.